Wescott Financial Advisory Group »

Effector Therapeutics shares owned by Wescott Financial Advisory Group

Quarter-by-quarter ownership of Effector Therapeutics shares owned by Wescott Financial Advisory Group from 13F filings

Historical chart of Wescott Financial Advisory Group investment in Effector Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Effector Therapeutics held by Wescott Financial Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Effector Therapeutics by Wescott Financial Advisory Group

Quarter filed Position value Share count Share price at filing
2023-09-30 $18k 31k 0.60
2023-06-30 $25k 31k 0.83
2023-03-31 $11k 31k 0.35
2022-12-31 $17k 41k 0.43
2022-09-30 $32k 56k 0.58

More positions owned by Wescott Financial Advisory Group

Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Wellington Short Trm Tax Ex (VTES)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Ishares Tr Rus Mdcp Val Etf (IWS)
Ishares Tr Rus 1000 Etf (IWB)
Dimensional Etf Trust Global Real Est (DFGR)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Ishares Tr Core Msci Eafe (IEFA)
Merck & Co (MRK)
Apple (AAPL)
Dimensional Etf Trust Internatnal Val (DFIV)
Spdr Ser Tr Portfolio Sh Tsr (SPTS)
Ishares Tr Core Us Aggbd Et (AGG)

View all positions for Wescott Financial Advisory Group

Top funds holding Effector Therapeutics

Blackstone Group
Vanguard Group
Alyeska Investment Group
Parallel Advisors
Two Sigma Securities
Stifel Financial
Vontobel Holding
UBS Group
Wells Fargo & Company
Royal Bank of Canada
Jpmorgan Chase & Co
Bank of America Corporation

View all funds holding Effector Therapeutics